Market Tracker

12/02 5:16pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.07
Delayed Data
As of Dec 02
 +0.01 / +0.94%
Today’s Change
1.01
Today|||52-Week Range
5.15
-55.79%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.06
Today’s open1.05
Day’s range1.04 - 1.09
Volume205,919
Average volume (3 months)544,990
Market cap$69.4M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+42.52%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EPIXESSA Pharma Inc-0.01-0.21%
CAPRCapricor Therapeutic...+0.09+2.89%
NNVCNanoViricides Inc+0.02+1.79%
AFMDAffimed NV0.000.00%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts